Avantor, Inc. (AVTR)
17.29
+0.14
(+0.82%)
USD |
NYSE |
Oct 23, 16:00
17.29
0.00 (0.00%)
After-Hours: 20:00
Avantor Price to Book Value : 2.078 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.078 |
| October 22, 2026 | 2.061 |
| October 21, 2026 | 2.074 |
| October 20, 2026 | 1.997 |
| October 19, 2026 | 1.957 |
| October 16, 2026 | 1.973 |
| October 15, 2026 | 1.933 |
| October 14, 2026 | 1.886 |
| October 13, 2026 | 1.868 |
| October 12, 2026 | 1.861 |
| October 09, 2026 | 1.883 |
| October 08, 2026 | 1.849 |
| October 07, 2026 | 1.844 |
| October 06, 2026 | 1.854 |
| October 05, 2026 | 1.900 |
| October 02, 2026 | 1.843 |
| October 01, 2026 | 1.806 |
| September 30, 2026 | 1.808 |
| September 29, 2026 | 1.831 |
| September 28, 2026 | 1.837 |
| September 25, 2026 | 1.832 |
| September 24, 2026 | 1.848 |
| September 23, 2026 | 1.774 |
| September 22, 2026 | 1.795 |
| September 21, 2026 | 1.814 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.865 |
| September 17, 2026 | 1.906 |
| September 16, 2026 | 1.876 |
| September 15, 2026 | 1.855 |
| September 14, 2026 | 1.822 |
| September 11, 2026 | 1.780 |
| September 10, 2026 | 1.788 |
| September 09, 2026 | 1.788 |
| September 08, 2026 | 1.832 |
| September 04, 2026 | 1.799 |
| September 03, 2026 | 1.825 |
| September 02, 2026 | 1.760 |
| September 01, 2026 | 1.706 |
| August 31, 2026 | 1.747 |
| August 28, 2026 | 1.752 |
| August 27, 2026 | 1.756 |
| August 26, 2026 | 1.742 |
| August 25, 2026 | 1.733 |
| August 24, 2026 | 1.713 |
| August 21, 2026 | 1.738 |
| August 20, 2026 | 1.712 |
| August 19, 2026 | 1.677 |
| August 18, 2026 | 1.602 |
| August 17, 2026 | 1.622 |
| August 14, 2026 | 1.641 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Champions Oncology, Inc. | 16.88 |
| Medpace Holdings, Inc. | 31.92 |
| Personalis, Inc. | 7.169 |
| Adaptive Biotechnologies Corp. | 28.39 |
| 10X Genomics, Inc. | 11.29 |
Price to Book Value Related Metrics
| PS Ratio | 1.789 |
| Price to Free Cash Flow | 25.81 |
| Price | 17.29 |
| Earnings Yield | -4.90% |
| Market Cap | 11.70B |
| Operating PE Ratio | 21.81 |
| Normalized PE Ratio | 2058.33 |